Dexcom Inc. Stock
Price
Target price
€70.18
€70.18
0.630%
0.44
0.630%
€89.23
22.08.25 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
The Dexcom Inc. stock is trending slightly upwards today, with an increase of €0.44 (0.630%) compared to yesterday's price.
With 29 Buy predictions and not a single Sell prediction Dexcom Inc. is an absolute favorite of our community.
As a result the target price of 89 € shows a positive potential of 26.82% compared to the current price of 70.18 € for Dexcom Inc..
For the coming years our community has positive and negative things to say abot the Dexcom Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.630% | 1.402% | -3.133% | 7.837% | -7.046% | -17.250% | -22.474% |
| Henry Schein Inc. | 1.290% | 1.782% | -3.320% | -5.203% | -10.971% | -22.119% | 5.939% |
| Teleflex Inc. | -0.940% | 2.941% | 8.247% | -50.935% | -37.500% | -55.508% | -65.909% |
| Baxter International | 1.900% | 1.282% | -10.592% | -36.281% | -24.775% | -65.132% | -70.280% |
Comments
DexCom (NASDAQ:DXCM) is now covered by analysts at Argus. They set a "buy" rating and a $100.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at William Blair to a "strong-buy" rating.
Show more
Ratings data for DXCM provided by MarketBeat
News
2 Stocks to Buy on the Dip and Hold for 10 Years
Despite President Donald Trump's trade wars and concerns about a possible recession, equity markets have performed relatively well this year, with the S&P 500 (SNPINDEX: ^GSPC) up 10% since January
DexCom (DXCM) Q2 Revenue Jumps 15%
DexCom (NASDAQ:DXCM) reported its second-quarter 2025 results on July 30, 2025, delivering an upbeat performance highlighted by a revenue beat and continued expansion in the key type 2 diabetes
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2025.
Second Quarter 2025 Financial Highlights:
-
Revenue grew 15% year-over-year to
